A Case of Adalimumab-associated Pancytopenia and Reversible Lymphadenopathy

Adalimumab is a recombinant monoclonal antibody to tumor necrosis factor alpha (TNFα) used in the treatment of inflammatory and autoimmune conditions, including ulcerative colitis (UC). Adverse side effects include infection and injection-site cutaneous reactions; however, rare adverse events such a...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cureus
Asıl Yazarlar: Walsh, Leonard T, Patel, Ravi, Loloi, Justin, Jones, Kirk, Caler, Julie, Ayaz, Zain, Jain, Rohit
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Cureus 2018
Konular:
Internal Medicine
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6318094/
https://ncbi.nlm.nih.gov/pubmed/30648028
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.3477
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller